You are here

Press & News

Dr-Eliabeth-Finger-FTDDR-March-2021-blog.png

FEATURED RESEARCHER: Meet Dr. Elizabeth Finger

Patience.

This is how Elizabeth Finger, M.D., principal investigator of FOXY: A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia (FTD), handles this ...more >

News-FOXY-Spring-2021.png

FEATURED STUDY: FOXY-Intranasal Oxytocin for FTD

Having a specific treatment to address behavioral issues in persons diagnosed with frontotemporal degeneration (FTD) would provide some much-needed relief and may help return quality of life to...more >

FTDDR-4-years.png

FTD Registry Surpasses 4,200 before 4th Anniversary: March 28, 2021

Highlights from 2020, a historic year!

As the FTD Disorders Registry (FTDDR) reached its 4th Anniversary on March 28, 2021, we continue to surpass enrollment...more >

reg-revisions-2021.png

Registry Improves Registration Process and Updates Registrant Features in 2021

Changes improve user experience and collect additional data

Last month the FTD Disorders Registry launched a revised registration process to streamline the...more >

AFTD-2021-Ed-conference.png

AFTD 2021 Education Conference: May 13-14, 2021

The AFTD 2021 Education Conference was held virtually on May 13 and 14, 2021, from 12:00 to 4:00 p.m. Eastern time (9:00 a.m. to 1:00 p.m. Pacific). recordings of the sessions are available...more >